Table 1. Relationships between the expression level of GFAT1 and the clinicopathological variables of pancreatic cancer patients.
| Variables | No. | GFAT1 expression |
P-value | |
|---|---|---|---|---|
| Low No. (%) | High No. (%) | |||
| Gender | 0.218 | |||
| Male | 62 | 18 (29.0) | 44 (71.0) | |
| Female | 34 | 6 (17.6) | 28 (82.4) | |
| Age (years) | 0.724 | |||
| >60 | 49 | 13 (26.5) | 36 (73.5) | |
| ≤60 | 47 | 11 (23.4) | 36 (76.6) | |
| Tumor site | 0.810 | |||
| Head | 58 | 14 (24.1) | 44 (75.9) | |
| Body | 38 | 10 (26.3) | 28 (73.7) | |
| Tumor size (cm) | 0.939 | |||
| >3 | 66 | 17 (25.8) | 49 (74.2) | |
| ≤3 | 30 | 7 (25.0) | 21 (75.0) | |
| G: tumor grading | 0.355 | |||
| I–II | 85 | 23 (27.1) | 62 (72.9) | |
| III–IV | 11 | 1 (9.1) | 10 (90.9) | |
| pT stage | 1.000 | |||
| pT1-pT2 | 76 | 19 (25.0) | 57 (75.0) | |
| pT3-pT4 | 20 | 5 (25.0) | 15 (75.0) | |
| pN stage | 0.020 | |||
| Absent | 61 | 20 (32.8) | 41 (67.2) | |
| Present | 35 | 4 (11.4) | 31 (88.6) | |
| pM stage | 1.000 | |||
| Absent | 94 | 24 (25.5) | 70 (74.5) | |
| Present | 2 | 0 (00.0) | 2 (100.0) | |
| pTNM stage | 0.033 | |||
| I | 42 | 15 (35.7) | 27 (64.3) | |
| II–IV | 54 | 9 (16.7) | 45 (83.3) | |
Abbreviations: P-value was got by pearson chi-square tests. P < 0.05 indicated the differences had statistical significance.